What is BIOLASE MG?
BIOLASE MG stands at the forefront of the dental technology industry, specializing in the development and manufacturing of advanced laser systems. The company's core competency lies in its hard- and soft-tissue laser platforms, which are engineered to enhance clinical precision while significantly improving patient outcomes. By prioritizing minimally invasive techniques, BIOLASE MG addresses the growing demand for restorative, surgical, endodontic, and periodontal solutions that minimize discomfort and accelerate recovery times.
The company's market position is defined by its commitment to innovation and clinical excellence. Beyond hardware, BIOLASE MG provides a comprehensive ecosystem of training and support, ensuring that dental professionals globally can integrate these sophisticated medical devices into their practices effectively. This holistic approach to dental health technology has established the firm as a pivotal player in the evolution of modern dentistry.
How much funding has BIOLASE MG raised?
BIOLASE MG has raised a total of $89.5M across 9 funding rounds:
Debt
$8M
Share Placement
$5M
Share Placement
$35M
Share Placement
$10M
Share Placement
$12M
Debt
$6M
Stock Offering
$8.5M
Debt
$3M
Debt
$2M
Debt (2012): $8M with participation from Comerica
Share Placement (2014): $5M led by Oracle Partners L.P
Share Placement (2014): $35M supported by Oracle Partners, L.P., Birchview Capital L.P., Eagle Growth Partners I and II, Camber Capital Management, LLC, Jack W. Schuler Living Trust, and Trellus Partners
Share Placement (2016): $10M featuring Oracle Partners L.P. and Jack W. Schuler Living Trust
Share Placement (2017): $12M backed by Oracle Investment Management and Jack W. Schuler
Debt (2018): $6M with participation from Bridge Bank
Stock Issuance/Offering (2019): $8.5M, investors not publicly disclosed
Debt (2019): $3M supported by Pacific Mercantile Bank
Debt (2020): $2M featuring PPP
Key Investors in BIOLASE MG
Oracle Partners, L.P.
A specialized investment firm with a long-standing history of supporting growth-stage medical technology and healthcare companies through strategic equity placements.
Pacific Mercantile Bank
A Southern California-based commercial bank providing comprehensive financial solutions, including working capital lines and equipment financing for small to medium-sized enterprises.
Comerica
A diversified financial services institution with a deep focus on business banking and wealth management, offering tailored debt structures for established corporate entities.
What's next for BIOLASE MG?
Looking ahead, the strategic deployment of the $2M is expected to accelerate the company's R&D pipeline and expand its global footprint. As BIOLASE MG continues to refine its laser-based medical devices, the focus will likely shift toward increasing market penetration in key geographic regions and enhancing the digital integration of its clinical support services.
The company is well-positioned to capitalize on the shift toward patient-centric, technology-driven dental care. By leveraging its established intellectual property and the support of its long-term financial backers, BIOLASE MG is poised to maintain its leadership in the dental laser market, driving sustainable growth and delivering high-value solutions to dental practitioners worldwide.
